Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
42 U.S.C. 1320f-1 Selection of negotiation-eligible drugs as selected drugs
42 U.S.C. 1320f-1 Selection of negotiation-eligible drugs as selected drugs, “Selection of negotiation-eligible drugs as selected drugs”, is a U.S. Code section of Part E—Price Negotiation Program to Lower Prices for Certain High-Priced Single Source Drugs; in force.
https://ontology.bommaritollc.com/id/01a0f07c-e07c-7216-b5a8-3e53bef1458d
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 42 U.S.C. 1320f-1 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Selection of negotiation-eligible drugs as selected drugsen |
| schema:url | |
| skos:prefLabel | 42 U.S.C. 1320f-1 Selection of negotiation-eligible drugs as selected drugsen |
Related
Cited by (14)eli:cites
- 42 U.S.C. 1320f Establishment of program
- 42 U.S.C. 1320f-2 Manufacturer agreements
- 42 U.S.C. 1320f-3 Negotiation and renegotiation process
- 42 U.S.C. 1320f-5 Administrative duties and compliance monitoring
- 42 U.S.C. 1320f-6 Civil monetary penalties
- 42 U.S.C. 1320f-7 Limitation on administrative and judicial review
- 42 U.S.C. 1395l Payment of benefits
- 42 U.S.C. 1395w-102 Prescription drug benefits
- 42 U.S.C. 1395w-104 Beneficiary protections for qualified prescription drug coverage
- 42 U.S.C. 1395w-114b Manufacturer rebate for certain drugs with prices increasing faster than inflation
- 42 U.S.C. 1395w-114c Manufacturer discount program
- 42 U.S.C. 1395w-22 Benefits and beneficiary protections
- 42 U.S.C. 1395w-3a Use of average sales price payment methodology
- 42 U.S.C. 1396r-8 Payment for covered outpatient drugs